entertainment -WSS

entertainment

author：knowledge 2025-10-01 11:43:57 - browse：3985

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： In Memoriam: Notable people who died in 2023
Next article： Health officials lay out plans to cope with respiratory virus season

WSS

Intellia plays down concerns on accidental germline transmission

Former Pear Therapeutics executives start new VC firm

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Abortion policy in the spotlight at Republican debate

Helping hospitals and community health centers plan for resilience

NVIDIA and Google execs on the future of AI and drug discovery

focus

entertainment

Sign up for D.C. Diagnosis

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

As obesity drug market grows, telehealth companies court payers

Activists slam private health insurers over coverage restrictions

It's time to retire 'poor historian' from clinicians' vocabularies

Medical records are filled with copy

Bird flu: Don't repeat Covid's 'health versus the economy' framing

DIEP, the 'gold standard' of breast reconstruction, is under threat

Listen: Vivek Ramaswamy's star turn & leaky drug data

Sports medicine is finally prioritizing gender equality

Readers respond to H5N1 and livestock movements, and more

entertainment

Readers respond to H5N1 and livestock movements, and more

Listen: Vivek Ramaswamy's star turn & leaky drug data

Case highlights the risks of experimental stem cell therapy

Roche's accidental data boosts hopes for anti

Health officials lay out plans to cope with respiratory virus season

Anxious about a speech? A startup wants you to pop a minty cardiac drug

knowledge

entertainment

hotspot

focus